Westlake Chemical's stock experienced a significant pre-market plunge, dropping 5.95% on Wednesday.
The sharp decline comes after several major financial institutions issued negative revisions. JP Morgan downgraded the stock to Underweight from Neutral, while Wells Fargo cut its price target to $110 from $125 and Morgan Stanley lowered its target to $106 from $115.
These analyst actions highlight growing concerns about the company's prospects, which were recently discussed during its Q1 earnings call where it noted setbacks alongside recovery momentum.